negative side effects of tirzepatide (Zepbound) for weight loss Long-Term Safety of Tirzepatide: What

E.MajounieE.WaiteA.Simn-SnchezJ.RollinsonS.GibbsJ

The overall incidence was 7.92%, estimated at 8% for semaglutide, 7% for liraglutide, 6% for dulaglutide, and 0.14% for tirzepatide

The gut is no longer taken as a mere food breaking system, but a complicated ecosystem of trillions of microorganisms that engage with the body in various manners

Breastfeeding during therapy with oral weight loss medication is not recommended due to the unknown risks associated with potential accumulation of SNAC in the infant

Howell-Jolly Bodies most commonly arise when spleen is absent or spleen function is impaired (hyposplenia)

Initial assessment typically involves liver function tests (ALT, AST, ALP, bilirubin, albumin), metabolic screening (glucose, HbA1c, lipid profile), and viral hepatitis serology, in line with British Society of Gastroenterology (BSG) guidance on abnormal liver blood tests